Therapy News and Research

RSS
Study to investigate clinical impact of new treatment for HFrEF patients

Study to investigate clinical impact of new treatment for HFrEF patients

Study suggests possibility for small molecule drug/antibody combinatorial therapy to treat neuroblastoma

Study suggests possibility for small molecule drug/antibody combinatorial therapy to treat neuroblastoma

Study finds strong link between childhood adversity and bipolar disorder diagnosis

Study finds strong link between childhood adversity and bipolar disorder diagnosis

Novel biomarkers enhance power to predict therapeutic efficacy in LN prognostic models

Novel biomarkers enhance power to predict therapeutic efficacy in LN prognostic models

Novel microwave-induced photodynamic therapy could target deeply situated tumors

Novel microwave-induced photodynamic therapy could target deeply situated tumors

Research on naked mole-rats could pave way for new human pain therapies

Research on naked mole-rats could pave way for new human pain therapies

Experts receive federal grant to improve mental health services for sexually exploited youth

Experts receive federal grant to improve mental health services for sexually exploited youth

Aerobic exercise provides benefits to T1D patients on insulin pump therapy

Aerobic exercise provides benefits to T1D patients on insulin pump therapy

Mental math exercises linked to better emotional health

Mental math exercises linked to better emotional health

New review questions safety of estrogen replacement therapy

New review questions safety of estrogen replacement therapy

Behavioral activation as effective as CBT? An interview with Professor David Richards

Behavioral activation as effective as CBT? An interview with Professor David Richards

Estrogen receptor degrader increases progression-free survival in advanced breast cancer patients

Estrogen receptor degrader increases progression-free survival in advanced breast cancer patients

Combination treatment with CDK4/6 inhibitor improves progression-free survival in HR+ breast cancer patients

Combination treatment with CDK4/6 inhibitor improves progression-free survival in HR+ breast cancer patients

PARP inhibitor prolongs progression-free survival in patients with recurrent ovarian cancer

PARP inhibitor prolongs progression-free survival in patients with recurrent ovarian cancer

Immunotherapy redefines treatment approach for metastatic bladder cancer patients

Immunotherapy redefines treatment approach for metastatic bladder cancer patients

Immune checkpoint inhibitor as adjuvant therapy improves overall survival in patients with stage III melanoma

Immune checkpoint inhibitor as adjuvant therapy improves overall survival in patients with stage III melanoma

Kessler Foundation receives Spinal Cord Injury Model System Grant from NIDILRR

Kessler Foundation receives Spinal Cord Injury Model System Grant from NIDILRR

Penn State scientists develop citrate-based fluorescent sensor for diagnosis of cystic fibrosis

Penn State scientists develop citrate-based fluorescent sensor for diagnosis of cystic fibrosis

Research finds disparity in rates of prostate cancer treatment among African-American, Hispanic men

Research finds disparity in rates of prostate cancer treatment among African-American, Hispanic men

First comprehensive center opened in Tri-State area to mark new era in care of DMD patients

First comprehensive center opened in Tri-State area to mark new era in care of DMD patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.